Corgenix Medical Corporation has been recognized for outstanding research presented today at the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo 2014 in Chicago.
One of the major revolutions taking place in healthcare is the rise of personalized medicine, which is the practice of using genomic and other molecular analyses to tailor medical treatments to a patient’s individual biology. Personalized diagnostics—laboratory analyses that inform the practice of personalized medicine—will play a major role in the lab’s future. This fall, AACC’s first ever virtual conference will feature the latest science in this exciting field and the novel technologies driving it forward, all in a convenient format that people can access without leaving their offices or homes.
AACC is pleased to announce the recipients of the AACC 2014 Corporate Supporter Awards. Each year, AACC recognizes the companies and organizations that generously support the association through sponsorships, advertising, and exhibiting. These significant contributions make it possible for AACC to improve patient care by fostering research, innovation, and professional excellence in the field of laboratory medicine.
As one of the 10 largest medical exhibitions in the U.S., the 2014 AACC Annual Meeting & Clinical Lab Expo is the place where breakthrough innovations in clinical testing and patient care are introduced to the healthcare world. This year, many of the trailblazing products displayed by the Expo’s 650 exhibitors will include the latest diagnostic technology in the field of mobile health.
The new, bench top P500, medium throughput, clinical chemistry analyzer and the Abacus 3CP hematology analyzer with cap piercing feature are shown on Diatron booth Nr. 1118.
PrimerDesign has today announced the launch of the World's most affordable qPCR Machine. The new instrument shatters typical market pricing coming in at $6500 for a high spec 16-well instrument.
Anteo Diagnostics, the inventor and develop of the Mix&Go molecular velcro surface chemistry is please to announce the launch of the Mix&Go based AMG™ Coupling Kit at the 2014 AACC Annual Meeting & Clinical Expo in Chicago.
CHICAGO, I.L. – July 29, 2014 - OHAUS Corporation, a leading manufacturer and marketer of high quality balances and scales, is set to announce the launch of its new Adventurer line of analytical and precision balances at the American Association for Clinical Chemistry (AACC) Annual Meeting in Chicago July 29-31. The new Adventurers, which will be available for purchase beginning in late September 2014, will be on display in OHAUS Booth #4473 for the duration of the AACC meeting.
CHICAGO, I.L. – July 29, 2014 - OHAUS Corporation, a leading manufacturer and marketer of high quality balances and scales, is set to announce the launch of its new Adventurer line of analytical and precision balances at the American Association for Clinical Chemistry (AACC) Annual Meeting in Chicago July 29-31. The new Adventurers, which will be available for purchase beginning in late September 2014, will be on display in OHAUS Booth #4473 for the duration of the AACC meeting.
Compact Dry is a self-contained device containing a membrane matrix saturated with a culture medium and a gelling agent, and then dried. A diluted food sample (1mL) is added to the center of the device, which diffuses automatically and evenly throughout the plate. The device is then incubated, after which a technician counts the colonies.
The Vision MINI Xi smart camera is the world's smallest machine vision system available with embedded Ethernet connectivity. Housed in our patented mini design and featuring built in lens and LED lighting, our award-winning compact smart camera is now available for flexible implementation of machine vision inspection (from decoding to color matching to OCR and more) into industrial environments. The Vision MINI Xi has corner-exit cables with both serial and Ethernet options to meet any connectivity requirement in space-constrained applications, and also packs 24 V interface, optically isolated I/O, and autofocus into its tiny form factor for powerful machine vision tasks with a small footprint.
The Precision Fluidics Division of Parker Hannifin Corporation, the global leader in motion and control technologies, announces the release of its newest Diaphragm Isolation liquid Valve. This 6.4 mm diaphragm isolation valve improves performance of Clinical Diagnostic and Analytical Chemistry systems requiring precision fluid and delivers liquid dispense performance in a very small package. At just 6.4 mm wide it can be easily mounted over microplates improving performance and saving space. When mounted on a manifold the R6’s ultra-small footprint enables smaller and more efficient fluidic circuits by taking less space and shortening fluid channels. The R6 provides solutions to today’s demanding analytical, clinical and agent detection applications.
Focus Diagnostics received expedited FDA 510(k) clearance and CLIA moderate complexity categorization for its new Simplexa HSV 1 & 2 Direct molecular test on the Integrated Cycler. The test, which is now available for purchase in the United States, is the first molecular test to be cleared by the FDA for the qualitative detection and differentiation of herpes simplex virus 1 (HSV-1) and herpes simplex virus 2 (HSV-2) in cerebrospinal fluid (CSF) from patients suspected of HSV central nervous system (CNS) infection, including encephalitis. The test uses a proprietary process that eliminates nucleic acid extraction, so clinicians can expect results within about an hour after providing a specimen for testing.
Abbott is developing diagnostic solutions for today and tomorrow, which it will showcase during the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, July 27 through July 31, 2014, in Chicago.
The groundbreaking scientific studies featured at the 2014 AACC Annual Meeting & Clinical Lab Expo will include research on a blood test for Alzheimer’s that uses biochip technology, a new test to diagnose colon cancer early, a more accurate method for determining multiple myeloma prognosis, a less stressful test for sleep apnea, and the development of a bank of biospecimens from pregnant women that could prove crucial for women’s health research.
Atomo Diagnostics is introducing the world’s first integrated rapid blood test device to the USA market at the 2014 AACC Annual Meeting & Clinical Lab Expo (July 27-31) following a successful presentation at the 20th International AIDS Conference 2014 in Melbourne (July 20 -25, 2014).
The new A2 (A-squared) Multiplex IA glass slide offers the user an open platform from which to prepare quantitative multiplex immunoassays of their choice